Manasi Manasvi

Dr. Manasi Manasvi

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
IMIshika Mahajan
Ishika Mahajan
Aruni GhoseAruni Ghose
Aruni Ghose
DGDeepika Gupta
Deepika Gupta
MMManasi Manasvi
Manasi Manasvi
SBSaisha Bhandari
Saisha Bhandari
Stergios BoussiosStergios Boussios
Stergios Boussios
COVID-19 has been responsible for widespread morbidity and mortality worldwide. Invasive mucormycosis has death rates scaling 80%. India, one of the countries hit worst by the pandemic, is also a hotbed with the highest death rates for mucormycosis. Cancer, a ubiquitously present menace, also contributes to higher case fatality rates. All three entities studied here are individual, massive healthcare threats. The danger of one disease predisposing to the other, the poor performance status of patients with all three diseases, the impact of therapeutics for one disease on the pathology and therapy of the others all warrant physicians having a better understanding of the interplay. This is imperative so as to effectively establish control over the individual patient and population health. It is important to understand the interactions to effectively manage all three entities together to reduce overall morbidity. In this review article, we search for an inter-relationship between the COVID-19 pandemic, emerging mucormycosis, and the global giant, cancer.


28 January 2026 in HPB
Verified
Journal Article
Closed access
UAUtpal Anand
Utpal Anand
AAAbhishek Arora
Abhishek Arora
PBPunam Bhadani
Punam Bhadani
KPKunal Parasar
Kunal Parasar
BSBasant Narayan Singh
Basant Narayan Singh
MMManasi Manasvi
Manasi Manasvi